Drug giant Bayer acquires RTP gene therapy startup AskBio for as much as $4B The Citizen 5 years ago Drug giant Bayer is paying quite a price to acquire RTP gene therapy startup AskBio in a deal announced early today – as much as $4 billion. Source: WRAL News Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Share on Pinterest (Opens in new window) Pinterest Share on WhatsApp (Opens in new window) WhatsApp Hyperloop startup Virgin One to showcase its tech at Triangle summit, in RTPDateOctober 9, 2019In relation toNewsPentagon-backed RTP startup eyes Johnston County for rare-earth magnets plantDateNovember 17, 2025In relation toMarshallbergEli Lilly returns to RTP with $470M plant for diabetes drugsDateJanuary 22, 2020In relation toNews
